Home・Stock List・Champions Oncology Inc

C
Champions Oncology Inc

Open

SectorHealthcare

5.37 0.19

Buy Sell

Overview

Share price change

24h

Current

Min

5.26

Max

5.55

Key metrics
By Trading Economics
Income	-389K -667K
Sales	1.5M 17M
P/E Sector Avg	35.118 64.641
EPS	-0.05
Profit margin	-4.028
Employees	213
EBITDA	-626K -522K

Dividends
By Acuity
Next Earnings	11 Sept 2026

Market Stats
By TradingEconomics
Market Cap	-555K 84M
Previous open	5.18
Previous close	5.37

News Sentiment

By Acuity

15%

85%

25 / 340 Healthcare

Champions Oncology Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

31 Jul 2026, 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

30 Jul 2026, 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

29 Jul 2026, 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

28 Jul 2026, 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

27 Jul 2026, 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

24 Jul 2026, 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

22 Jul 2026, 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Peer Comparison

Price change

Champions Oncology Inc Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Champions Oncology Inc - Dist in the past 3 months.

Sentiment

By Acuity

25 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.